Drug intelligence / Profile preview

immunoBON

Development stage
Unknown
Lead developer
ERWO Pharma
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

immunoBON is a dietary food for special medical purposes (FSMP) developed for the management of allergic rhinitis, including hay fever, house dust mite, and pet hair allergies. The product is based on the "farm effect," a phenomenon where exposure to traditional farm environments protects against the development of allergies. The active ingredient is a proprietary whey protein complex containing **beta-lactoglobulin (BLG)**, a lipocalin protein that acts as a carrier for essential micronutrients such as iron, zinc, and vitamin A (retinoic acid). By delivering these ligands directly to immune cells, immunoBON helps stabilize the immune system and promotes the induction of immune tolerance, thereby reducing the allergic inflammatory response. It is administered as a lozenge to facilitate mucosal uptake.

Brand names
immunoBON
Other names
Whey protein complexBeta-lactoglobulin complex
02

Targets

RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on immunoBON.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on immunoBON.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call